45.00 +0.51 (1.14%)
RHHBY
| Trade RHHBY now with |
|
Stock Details
Last Trade:45.00 Change:+0.51 (1.14%) Prev Close:44.49 Open: 44.83 Days Range:44.55 – 45.00 52 Week Range: 34.02 - 45.65 Volume:679953 P/E: N/AEPS:0.00
View AllRecent Alerts 02/09/12
Recent Alert on 02/06/12 at 3:27pm
Citi Maintains a 'Neutral' on Regeneron Pharma (REGN); Doctors Consider Eylea as Replacement for Roche's Lucentis
Citi Maintains a 'Neutral' on Regeneron Pharma (REGN); Doctors Consider Eylea as Replacement for Roche's Lucentis
Citi maintains a 'Neutral' on Regeneron Pharma (NASDAQ: REGN) price target of $68. Analyst, Yaron Werber, suggested that recent channel checks indicate doctors are really considering switching to REGN's Eylea from Roche's (OTC: RHHBY) Lucentis,... Read More
Recent Alert on 01/31/12 at 7:43am
Oppenheimer Reiterates an 'Outperform' on Curis (CRIS); Approval Ahead Of Schedule
Oppenheimer Reiterates an 'Outperform' on Curis (CRIS); Approval Ahead Of Schedule
View AllRecent Press Releases
Press Release on 02/08/12 at 1:13am
Roche disappointed by the actions of Illumina, Inc.’s Board of Directors
Roche disappointed by the actions of Illumina, Inc.’s Board of Directors
Press Release on 02/07/12 at 12:00pm
FDA Grants Genentech’s Pertuzumab Priority Review for Previously Untreated HER2-Positive Metastatic Breast Cancer
FDA Grants Genentech’s Pertuzumab Priority Review for Previously Untreated HER2-Positive Metastatic Breast Cancer
View AllRecent SEC Filings
No Recent SEC Filings Available
View AllRecent Blog Posts
Blog Posts on 12/07/10 at 12:05pm
Analyst Calls: AZN, DG, GSK, NBS, NRGY, NVS, RHT, SFD, STX, TYC ...
Analyst Calls: AZN, DG, GSK, NBS, NRGY, NVS, RHT, SFD, STX, TYC ...
Blog Posts on 09/22/10 at 11:40am
Analyst Calls: ADBE, AXP, BAX, COST, DLB, FDX, HOT, NOK, NVS, TWX ...
Analyst Calls: ADBE, AXP, BAX, COST, DLB, FDX, HOT, NOK, NVS, TWX ...